Frontline Treatment of Localized Osteosarcoma Without Methotrexate: Results of the St. Jude Children's Research Hospital OS99 Trial

BACKGROUND: Standard treatment of osteosarcoma includes cisplatin and high-dose methotrexate (HDMTX); both agents exert significant toxicity, and HDMTX requires complex pharmacokinetic monitoring and leucovorin rescue. In our previous OS91 trial, treatment of localized disease with carboplatin, ifos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daw, Najat C., Neel, Michael D., Rao, Bhaskar N., Billups, Catherine A., Wu, Jianrong, Jenkins, Jesse J., Quintana, Juan, Luchtman-Jones, Lori, Villarroel, Milena, Santana, Victor M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535449/
https://ncbi.nlm.nih.gov/pubmed/21656756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25715
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados